<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0213-9111</journal-id>
<journal-title><![CDATA[Gaceta Sanitaria]]></journal-title>
<abbrev-journal-title><![CDATA[Gac Sanit]]></abbrev-journal-title>
<issn>0213-9111</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Salud Pública y Administración Sanitaria (SESPAS)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0213-91112025000103402</article-id>
<article-id pub-id-type="doi">10.1016/j.gaceta.2025.102460</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[The opportunity cost of funding new medicines: an attempt to measure the invisible]]></article-title>
<article-title xml:lang="es"><![CDATA[El coste de oportunidad de financiar nuevos medicamentos: un intento de medir lo invisible]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vallejo-Torres]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vanness]]></surname>
<given-names><![CDATA[David J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paulden]]></surname>
<given-names><![CDATA[Mike]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Claxton]]></surname>
<given-names><![CDATA[Karl]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,University of Las Palmas de Gran Canaria Department of Quantitative Methods in Economics and Management ]]></institution>
<addr-line><![CDATA[Canary Islands ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Pennsylvania State University University Park Department of Health Policy and Administration]]></institution>
<addr-line><![CDATA[ Pennsylvania]]></addr-line>
<country>United States of America</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,University of Alberta School of Public Health ]]></institution>
<addr-line><![CDATA[Edmonton Alberta]]></addr-line>
<country>Canada</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,University of York Centre for Health Economics ]]></institution>
<addr-line><![CDATA[York ]]></addr-line>
<country>United Kingdom</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>39</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0213-91112025000103402&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0213-91112025000103402&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0213-91112025000103402&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naci]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Woods]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000-20: a retrospective analysis]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2025</year>
<volume>405</volume>
<page-range>50-60</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Department of Health and Social Care</collab>
<source><![CDATA[Direct and indirect health impacts of COVID-19 in England: Short paper]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Claxton]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold]]></article-title>
<source><![CDATA[Health Technol Assess]]></source>
<year>2015</year>
<volume>19</volume>
<page-range>1-503</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lomas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Claxton]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimating the marginal productivity of the English National Health Service from 2003 to 2012]]></article-title>
<source><![CDATA[Value Health]]></source>
<year>2019</year>
<volume>22</volume>
<page-range>995-1002</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo-Torres]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[García-Lorenzo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano-Aguilar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimating a cost-effectiveness threshold for the Spanish NHS]]></article-title>
<source><![CDATA[Health Econ]]></source>
<year>2018</year>
<volume>27</volume>
<page-range>746-61</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo-Torres]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimating the incremental cost per QALY produced by the Spanish NHS: a fixed-effect econometric approach]]></article-title>
<source><![CDATA[PharmacoEconomics]]></source>
<year>2025</year>
<volume>43</volume>
<page-range>109-22</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
